Literature DB >> 20449587

Morphologic imaging in muscular dystrophies and inflammatory myopathies.

Adrian Degardin1, David Morillon, Arnaud Lacour, Anne Cotten, Patrick Vermersch, Tanya Stojkovic.   

Abstract

OBJECTIVE: To determine if magnetic resonance imaging (MR imaging) is useful in the diagnostic workup of muscular dystrophies and idiopathic inflammatory myopathies for describing the topography of muscle involvement.
MATERIALS AND METHODS: MR imaging was performed in 31 patients: 8 with dystrophic myotony types 1 (n = 4) or 2 (n = 4); 11 with limb-girdle muscular dystrophy, including dysferlinopathy, calpainopathy, sarcoglycanopathy, and dystrophy associated with fukutin-related protein mutation; 3 with Becker muscular dystrophy; and 9 with idiopathic inflammatory myopathies, including polymyositis, dermatomyositis, and sporadic inclusion body myositis.
RESULTS: Analysis of T1 images enabled us to describe the most affected muscles and the muscles usually spared for each muscular disease. In particular, examination of pelvis, thigh, and leg muscles demonstrated significant differences between the muscular diseases. On STIR images, hyperintensities were present in 62% of our patients with muscular dystrophies.
CONCLUSION: A specific pattern of muscular involvement was established for each muscular disease. Hyperintensities observed on STIR images precede fatty degeneration and are not specific for inflammatory myopathies.

Entities:  

Mesh:

Year:  2010        PMID: 20449587     DOI: 10.1007/s00256-010-0930-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  19 in total

1.  Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis.

Authors:  Elisabeth Dion; Patrick Cherin; Christine Payan; Jean-Charles Fournet; Thomas Papo; Thierry Maisonobe; Eric Auberton; Olivier Chosidow; Pierre Godeau; Jean-Charles Piette; Serge Herson; Philippe Grenier
Journal:  J Rheumatol       Date:  2002-09       Impact factor: 4.666

2.  BOLD MRI mapping of transient hyperemia in skeletal muscle after single contractions.

Authors:  Ronald A Meyer; Theodore F Towse; Robert W Reid; Roop C Jayaraman; Robert W Wiseman; Kevin K McCully
Journal:  NMR Biomed       Date:  2004-10       Impact factor: 4.044

Review 3.  The use of MRI in the evaluation of myopathy.

Authors:  Steven Lovitt; Sandra L Moore; Franklin A Marden
Journal:  Clin Neurophysiol       Date:  2006-01-27       Impact factor: 3.708

4.  Proton spin-lattice relaxation time of Duchenne dystrophy skeletal muscle by magnetic resonance imaging.

Authors:  K Matsumura; I Nakano; N Fukuda; H Ikehira; Y Tateno; Y Aoki
Journal:  Muscle Nerve       Date:  1988-02       Impact factor: 3.217

5.  Magnetic resonance imaging of muscles in myotonic dystrophy.

Authors:  J Castillo; J M Pumar; J R Rodríguez; J M Prieto; L Arrojo; F Martínez; M Noya
Journal:  Eur J Radiol       Date:  1993-11       Impact factor: 3.528

Review 6.  Use of imaging to assess patients with muscle disease.

Authors:  David L Scott; Gabrielle H Kingsley
Journal:  Curr Opin Rheumatol       Date:  2004-11       Impact factor: 5.006

7.  Magnetic resonance imaging of children with Duchenne muscular dystrophy.

Authors:  A Schreiber; W L Smith; V Ionasescu; H Zellweger; E A Franken; V Dunn; J Ehrhardt
Journal:  Pediatr Radiol       Date:  1987

8.  Polymyositis: MRI-appearance at 1.5 T and correlation to clinical findings.

Authors:  R Stiglbauer; W Graninger; L Prayer; J Kramer; H Schurawitzki; K Machold; H Imhof
Journal:  Clin Radiol       Date:  1993-10       Impact factor: 2.350

9.  Miyoshi myopathy in Saudi Arabia: clinical, electrophysiological, histopathological and radiological features.

Authors:  E J Cupler; S Bohlega; R Hessler; D McLean; B Stigsby; J Ahmad
Journal:  Neuromuscul Disord       Date:  1998-06       Impact factor: 4.296

10.  Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.

Authors:  Marina Fanin; Anna Chiara Nascimbeni; Luigi Fulizio; Carlo Pietro Trevisan; Marija Meznaric-Petrusa; Corrado Angelini
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

View more
  23 in total

1.  [Early symptoms of dermatomyositis and antisynthetase syndrome].

Authors:  B Maurer
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

2.  A 61-year-old woman with progressive weakness and rash.

Authors:  Eric R Anderson; Jonathan D Glass; James G Greene
Journal:  Neurohospitalist       Date:  2012-04

Review 3.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

4.  Intramuscular leukemic relapse: clinical signs and imaging findings. A multicentric analysis.

Authors:  Alexey Surov; Hayyam Kiratli; Soo Ah Im; Yasuhiro Manabe; Alibhe O'Neill; Atul B Shinagare; Rolf Peter Spielmann
Journal:  Skeletal Radiol       Date:  2014-09-26       Impact factor: 2.199

Review 5.  Inclusion body myositis.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2014-06-06       Impact factor: 3.806

6.  MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot-Marie-Tooth type 2 F disease.

Authors:  Michele Gaeta; Achille Mileto; Anna Mazzeo; Fabio Minutoli; Rita Di Leo; Nicola Settineri; Rocco Donato; Giorgio Ascenti; Alfredo Blandino
Journal:  Skeletal Radiol       Date:  2011-05-25       Impact factor: 2.199

Review 7.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

8.  [18F]Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing polymyositis/dermatomyositis.

Authors:  Lu Sun; Yuanfei Dong; Na Zhang; Xing Lv; Qiusong Chen; Wei Wei
Journal:  Exp Ther Med       Date:  2018-04-13       Impact factor: 2.447

Review 9.  Inclusion body myositis.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

Review 10.  Idiopathic inflammatory myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.